The reduction in the M6A level of MYC mRNA occurs via the inhibition of HBXIP, which interrupts the METTL3-mediated M6A regulatory process, thereby ultimately impeding the proliferation, migration, and invasion of GC cells (84). Here, METTL3 is linked to gastric cancer.